Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy
- PMID: 7791440
- DOI: 10.1016/s0140-6736(95)91088-3
Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy
Abstract
We have investigated the influence of the functional insertion (I) and deletion (D) polymorphism in intron 16 of the gene for angiotensin-converting enzyme (ACE) in a retrospective study of 100 patients with IgA nephropathy. There was no difference in genotype frequency compared with normal subjects. However, patients homozygous for the D allele tended to present at an earlier age (medians: DD, 33; ID, 34; II, 42 years) and to require renal replacement therapy at a younger age (medians 37, 42, and 48 years, respectively). The rate of progression was significantly worse in patients homozygous for the D allele. The DD genotype is associated with increased severity of disease in patients with IgA nephropathy.
Comment in
-
ACE genotype and progression of IgA nephropathy.Lancet. 1995 Aug 26;346(8974):570; author reply 571. Lancet. 1995. PMID: 7658787 No abstract available.
-
ACE genotype and progression of IgA nephropathy.Lancet. 1995 Aug 26;346(8974):570; author reply 571. Lancet. 1995. PMID: 7658788 No abstract available.
-
ACE genotype and progression of IgA nephropathy.Lancet. 1995 Aug 26;346(8974):570; author reply 571. Lancet. 1995. PMID: 7658789 No abstract available.
-
ACE genotype and progression of IgA nephropathy.Lancet. 1995 Aug 26;346(8974):571. Lancet. 1995. PMID: 7658790 No abstract available.
-
ACE genotype and progression of IgA nephropathy.Lancet. 1995 Aug 26;346(8974):571-2. Lancet. 1995. PMID: 7658791 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
